* ALNYLAM PHARMACEUTICALS INC - COMPANY INTENDS TO INITIATE LUMASIRAN PHASE 3 STUDY IN MID-2018, WITH TOPLINE RESULTS EXPECTED IN 2019 * ALNYLAM PHARMACEUTICALS INC - IF LUMASIRAN PHASE 3 STUDY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback